Seema Kumar1, Jobayer Hossain1, Nicole Nader1, Roxana Aguirre1, Swetha Sriram1, P Babu Balagopal1. 1. Division of Pediatric Endocrinology, Department of Pediatric and Adolescent Medicine (S.K., S.S.), Mayo Clinic, Rochester, Minnesota 55905; Biostatistics Core (J.H.), Nemours Biomedical Research, Wilmington, Delaware 19803; Park Nicollet Health Services (N.N.), St Louis, Minnesota 55416; University of Illinois (R.A.), College of Medicine, Peoria, Illinois 61603; and Nemours Children's Specialty Care, Division of Biomedical Research (P.B.B.), Jacksonville, Florida; and Mayo Clinic College of Medicine, Jacksonville, Florida 32207.
Abstract
CONTEXT: Spexin is a novel peptide that is implicated in obesity and related energy homeostasis in animals and adult humans. Little is known about its role in children. OBJECTIVE: The aim of the current study was to determine the potential role of Spexin in obese children and explore its relationships with various cardiometabolic risk factors. DESIGN AND PARTICIPANTS: This was a cross-sectional study composed of 69 children (51 obese and 18 normal weight; age 15.3 ± 0.26 y). OUTCOME MEASURES: Spexin was measured using a specific enzyme-linked immunosorbent assay. Leptin, total and high-molecular-weight adiponectin, IL-6, high-sensitivity C-reactive protein, glucose, and insulin were also measured. Mann-Whitney U test, Pearson and Spearman rank correlations, logistic regression, and cluster analysis were used for the analysis and interpretation of the data. RESULTS: Spexin levels were significantly lower in obese vs normal-weight children, median(IQR) (0.33 ng/mL [0.27-0.44] vs 0.42 ng/mL [0.33-0.55]; P = .024), but did not correlate with other adipokines and/or insulin and glucose levels. Ordinal categorical variables of Spexin showed a strictly reverse association of obesity with the level of Spexin. Cluster analysis of Spexin and body mass index z score resulted in splitting the participants into normal-weight and obese-weight groups with high accuracy. CONCLUSIONS: Lower circulating levels of Spexin in obese children compared with their normal-weight counterparts and the ability to discriminate obese and normal-weight groups based on Spexin concentration enabled us to suggest a potential role for this novel peptide in childhood obesity. The clinical significance of these findings needs additional investigation.
CONTEXT: Spexin is a novel peptide that is implicated in obesity and related energy homeostasis in animals and adult humans. Little is known about its role in children. OBJECTIVE: The aim of the current study was to determine the potential role of Spexin in obesechildren and explore its relationships with various cardiometabolic risk factors. DESIGN AND PARTICIPANTS: This was a cross-sectional study composed of 69 children (51 obese and 18 normal weight; age 15.3 ± 0.26 y). OUTCOME MEASURES: Spexin was measured using a specific enzyme-linked immunosorbent assay. Leptin, total and high-molecular-weight adiponectin, IL-6, high-sensitivity C-reactive protein, glucose, and insulin were also measured. Mann-Whitney U test, Pearson and Spearman rank correlations, logistic regression, and cluster analysis were used for the analysis and interpretation of the data. RESULTS:Spexin levels were significantly lower in obese vs normal-weight children, median(IQR) (0.33 ng/mL [0.27-0.44] vs 0.42 ng/mL [0.33-0.55]; P = .024), but did not correlate with other adipokines and/or insulin and glucose levels. Ordinal categorical variables of Spexin showed a strictly reverse association of obesity with the level of Spexin. Cluster analysis of Spexin and body mass index z score resulted in splitting the participants into normal-weight and obese-weight groups with high accuracy. CONCLUSIONS: Lower circulating levels of Spexin in obesechildren compared with their normal-weight counterparts and the ability to discriminate obese and normal-weight groups based on Spexin concentration enabled us to suggest a potential role for this novel peptide in childhood obesity. The clinical significance of these findings needs additional investigation.
Authors: Andrea Porzionato; Marcin Rucinski; Veronica Macchi; Carla Stecco; Ludwik K Malendowicz; Raffaele De Caro Journal: J Histochem Cytochem Date: 2010-06-07 Impact factor: 2.479
Authors: Robert J Kuczmarski; Cynthia L Ogden; Shumei S Guo; Laurence M Grummer-Strawn; Katherine M Flegal; Zuguo Mei; Rong Wei; Lester R Curtin; Alex F Roche; Clifford L Johnson Journal: Vital Health Stat 11 Date: 2002-05
Authors: Freshet Assefa; Ju Ang Kim; Jiwon Lim; Sang-Hyeon Nam; Hong-In Shin; Eui Kyun Park Journal: Tissue Eng Regen Med Date: 2021-12-24 Impact factor: 4.169
Authors: Matthew K H Wong; Mulan He; Kong Hung Sze; Tao Huang; Wendy K W Ko; Zhao-Xiang Bian; Anderson O L Wong Journal: Front Endocrinol (Lausanne) Date: 2021-07-02 Impact factor: 5.555
Authors: Matthew K H Wong; Yuan Chen; Mulan He; Chengyuan Lin; Zhaoxiang Bian; Anderson O L Wong Journal: Front Endocrinol (Lausanne) Date: 2021-07-02 Impact factor: 5.555